Follow

Submissions from 2020

Link

ASO Author Reflections: Oncoplastic Surgery Does Not Compromise Surveillance Imaging., Angelena Crown and Janie Grumley

Link

Evaluating Need for Additional Imaging and Biopsy After Oncoplastic Breast-Conserving Surgery., Angelena Crown, Ruby Laskin, Christina Weed, Flavio G Rocha, and Janie Grumley

Link

Disparities in the Occurrence of Late Effects following Treatment among Adolescent and Young Adult Melanoma Survivors., Alicia A Gingrich, Candice A M Sauder, Melanie Goldfarb, Qian Li, Ted Wun, and Theresa H M Keegan

Link

Parathyroidectomy for Patients With Primary Hyperparathyroidism and Associations With Hypertension., Amanda N Graff-Baker, Letitia T Bridges, Qiaoling Chen, Mark B Faries, and Meena Said

Link

MP70-07 TRANSPERINEAL FOCAL CRYOABLATION AS A TREATMENT FOR CLINICALLY SIGNIFICANT PROSTATE CANCER, Mark J. Kelly and Jonatan Torrez

Link

Reply to Barner and Bruno-Murtha., Ravina Kullar, Jerod Nagel, Susan C Bleasdale, Sarah H Sutton, Snezana Naumovski, Cheryl Smith, James E Leggett, Dana Wollins, Chris Busky, and Ellie J C Goldstein

Link

Massive cotyledenoid leiomyoma treated with uterine-conserving surgery., William H Parker, Roderick Turner, Stanford Schwimer, and Lee Foshag

PDF

Genetic Variants in Immune Related Genes as Predictors of Responsiveness to BCG Immunotherapy in Metastatic Melanoma Patients., Romela Irene Ramos, Misa A Shaw, Leland J Foshag, Stacey L Stern, Negin Rahimzadeh, David Elashoff, and Dave Hoon

Link

A Pilot Study to Assess the Integration of a Unique PROQOL Tool and Early Palliative Care Intervention in the Care of High Grade Glioma Patients and their Caregivers (2633), Akanksha Sharma and See full list of authors in comments

Link

Longitudinal Perception of Prognosis of Patients with High Grade Glioma Compared to their Caregivers and Clinicians (2588), Akanksha Sharma and See full list of authors in comments

Submissions from 2019

Link

Glioblastoma: Biology, Diagnosis, and Treatment, Akanksha Sharma, Maciej M. Mrugala, and Jan Buckner

Submissions from 2018

A Tale of Two Bladders- High-Grade Non-muscle Invasive Bladder Cancer and Muscle Invasive Bladder Cancer: Evolving treatment paradigms, Mark J. Kelly

Focal Ablation for Locally Advance Prostate Cancer, Mark J. Kelly

Submissions from 2017

Clinical Stage I vs Clinical Stage II Seminoma. Nuances and Assessing Treatment Guidelines, Mark J. Kelly

Submissions from 2015

Nephron Sparing Surgery vs Ablation for Hilar Renal Cell Carcinoma. Case Presentation and Literature Review, Mark J. Kelly

The Evaluation and Management of Urinary Retention in the Acute Care Setting, Mark J. Kelly

Tumor Board Presentation; Topics: 1. Current Management of Renal Angiomyolipoma 2. Update of NCCN Management of Pathological T2 Bladder Cancer, Mark J. Kelly

Submissions from 2014

Active Surveillance for Men with Low-Risk Adenocarcinoma of the Prostate. “Who Is a Candidate for Surveillance, Who Is Not?”, Mark J. Kelly

Reconciling the R.E.N.A.L. Nephrometry Tool and the updated NCCN Management Guidelines for Kidney Cancer. “Upholding Oncological Principles and Avoiding Chronic Kidney Disease.”, Mark J. Kelly

Squamous Cell Carcinoma of the Penis. Natural History, Epidemiology, Diagnosis, Staging and Management, Mark J. Kelly

The use of multiparimetric MRI Imaging in the Management of Clinically Localized Prostate Cancer, Mark J. Kelly